doi: 10.1177/1758834011423402.
c-MET: an exciting new target for anticancer therapy
Affiliations
- PMID: 22128286
- PMCID: PMC3225019
- DOI: 10.1177/1758834011423402
Item in Clipboard
c-MET: an exciting new target for anticancer therapy
Ther Adv Med Oncol.
2011 Nov.
No abstract available
Similar articles
-
Reversal of c-MET-mediated Resistance to Cytotoxic Anticancer Drugs by a Novel c-MET Inhibitor TAS-115.Anticancer Res. 2015 Oct;35(10):5241-7. Anticancer Res. 2015. PMID: 26408683
-
Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016-Present).Molecules. 2020 Jun 8;25(11):2666. doi: 10.3390/molecules25112666. Molecules. 2020. PMID: 32521825 Free PMC article. Review.
-
Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.Eur J Med Chem. 2016 Jan 27;108:495-504. doi: 10.1016/j.ejmech.2015.12.016. Epub 2015 Dec 13. Eur J Med Chem. 2016. PMID: 26717201 Review.
-
Discovery of a new series of imidazo[1,2-a]pyridine compounds as selective c-Met inhibitors.Acta Pharmacol Sin. 2016 May;37(5):698-707. doi: 10.1038/aps.2016.11. Epub 2016 Apr 4. Acta Pharmacol Sin. 2016. PMID: 27041462 Free PMC article.
-
Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2.Eur J Med Chem. 2018 Oct 5;158:814-831. doi: 10.1016/j.ejmech.2018.09.050. Epub 2018 Sep 18. Eur J Med Chem. 2018. PMID: 30248654
Cited by
-
PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral Cancer Cells.Int J Mol Sci. 2024 Mar 1;25(5):2871. doi: 10.3390/ijms25052871. Int J Mol Sci. 2024. PMID: 38474118 Free PMC article.
-
Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches.Cancers (Basel). 2023 Sep 14;15(18):4552. doi: 10.3390/cancers15184552. Cancers (Basel). 2023. PMID: 37760522 Free PMC article. Review.
-
Comparison of the effects of crizotinib as monotherapy and as combination therapy with butyric acid on different breast cancer cells.Oncol Lett. 2024 Nov 1;29(1):38. doi: 10.3892/ol.2024.14784. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39530008 Free PMC article.
-
Role of savolitinib in advanced gastric adenocarcinoma with meningeal carcinomatosis and cerebellar metastasis: A case report.World J Clin Cases. 2024 May 26;12(15):2636-2641. doi: 10.12998/wjcc.v12.i15.2636. World J Clin Cases. 2024. PMID: 38817213 Free PMC article.
-
Role of cMET in the development and progression of colorectal cancer.Int J Mol Sci. 2013 Sep 3;14(9):18056-77. doi: 10.3390/ijms140918056. Int J Mol Sci. 2013. PMID: 24005867 Free PMC article. Review.
References
-
- Beau-Faller M., Ruppert A.M., Voegeli A.C., Neuville A., Meyer N., Guerin E., et al. (2008) MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naive cohort. J Thorac Oncol 3: 331–339 - PubMed
-
- Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. (2003) MET, metastasis, motility and more. Nature Rev Mol Cell Biol 4: 915–925 - PubMed
-
- Bladt F., Riethmacher D., Isenmann S., Aguzzi A., Birchmeier C. (1995) Essential role for the c-MET receptor in the migration of myogenic precursor cells into the limb bud. Nature 376: 768–771 - PubMed
-
- Boccaccio C., Comoglio P.M. (2006) Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6: 637–645 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
